NEW YORK (360Dx) – GE, the Global Good Fund, and Access Bio today announced a licensing agreement to manufacture and distribute diagnostic technologies aimed at rapidly identifying asymptomatic malaria in low-resource nations.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.